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The NpC-susceptibility protein and medullo-blastoma antigen, Ankyrin repeat domain 11 (ANKRD11, aka ANR11 or ANCO1), is a p53-interacting protein that enhances the activity of p53. As a member of the family of ankyrin repeats containing cofactors (ANCOs), ANKRD11 interact with p160 co-activators to inhibit ligand-dependent transactivation. ANKRD11 enhances the DNA-binding properties of mutant p53 (R273H) to the CDKN1A promoter, thus mediating the restoration of normal p53 function in some cancer-related p53 mutations [4] .
The identification of the proteomic signature of NpC, and tumor infiltrating lymphocyte populations (TILs) could ensure novel modes of detection and intervention. This study sought to define and to characterize biomarkers of activated signaling pathways, and of the populations of TILs in NpC tissue microarrays.
Immunohistochemistry (IHC) and immunohistofluorescence (IHF) imaging profiles of certain salient such markers converge to provide a novel perspective on the cellular immune surveillance in NpC.
We tested the PI3K/AKT/mTOR pathway because AKT (aka AKT1 of the protein kinase B [PKB] family) promotes several types of cancer by acting as an anti-apoptotic factor. AKT is activated through phosphatidylinositol 3-kinase (PI3K), and is critical for transmitting growth promoting signals, in large part, but not exclusively, by activating the mammalian target of rapamycin (mTOR), a regulator of cell growth, proliferation, motility, and survival [5, 6]. The PI3K/AKTmTOR pathway is often overactive in cancer, and favors cell division while reducing apoptosis, and has become the target of many efforts toward proteomics-based therapies [7] .
We tested for the invasion of CD8+ T cells, which are the principal population of TIL-Ts in several carcinomas, although the CD8 phenotypic cell surface marker is also displayed on natural killer and dendritic cells. Because TIL's-T are activated effector cells, we monitored cells that expressed the marker of activation CD38, the multifunctional ectoenzyme cyclic ADP ribose hydrolase, which catalyzes the synthesis and hydrolysis of cyclic ADP-ribose (cADPR), a regulator of Ca ++ flux. The loss of CD38 expression and function in CD8+ cells is associated with impaired immune responses, metabolic disturbances, and behavioral modifications. Activated B cells can also express CD38, and CD38+ B lymphocytes that express surface IgD, while remaining IgM-, can be selectively derived from human nasopharynx-associated lymphoid tissue. These activated B cells give rise to extrafollicular IgD+ plasma cells, which however remain stunted for downstream immunoglobulin class switch and cell maturation TILs-B constitutes a newly identified aspect of the immune surveillance mechanisms for a variety of malignancies. TILs-B, which account for 30-40% of the TILs, generally show evidence of maturation and recognize specific tumor and self-antigens. The presence of TILs-B yields a favorable outcome for tumor immune surveillance because they functionally associate closely with TILs-T and other tumor immune surveilling cell populations. In brief, and perhaps particularly in the instance of EBV infection of the nasopharyngeal epithelium, we propose that infiltrating activated B cells might play an important role to enhance T cell responses by producing specific antibody populations, by secreting stimulatory cytokines and chemokines, by serving as local antigen-presenting cells, and by organizing and sustaining the formation of tertiary lymphoid structures that can sustain long-term cellular immunity [11] . We also assessed regulatory immune cells expressing forkhead box P3 (FoxP3+) among CD8+ and CD38+ TILs, because experimental induction or administration of regulatory T cells (Tregs, CD4+/CD8+FoxP3+) can lead to marked reductions in cellular immunity, suggesting that cellular therapies targeting Tregs could help overcome diseases where immunotoxicity against certain targets, such as cancer, need to be maximized For IHC, primary antibodies were from Abcam (abcam.com). Mouse anti-human Epstein Barr Virus (EBV) Early Antigen Diffuse and Latent Membrane Protein were used at a dilution of 1:100. Mouse anti-human EBV Nuclear Antigen was used at a dilution of 1:50. Rabbit anti-human AKT and anti-human Pi3K proteins were used at the dilution of 1:50. Rabbit anti-human mTOR protein was used at the dilution of 1:250. Biotinylated secondary goat anti-rabbit antibody was used with the Vectastatin avidin-biotin complex (ABC) kit (VectorLaboratories, vectorlabs.com). Color was developed with the Vector Nova Red Substrate kit. For IHF, cell nuclei were stained with 4',6-diamidino-2-phenylindole (DAPI), a fluorescent stain that binds strongly to A-T rich regions of DNA (emission maximum: 461nm, blue visible region). Mouse monoclonal anti-human anti-CD8 antibody conjugated to fluorescein (Becton Dickinson, bd.com) (emission maximum: 521nm: green visible region), and mouse monoclonal antihuman anti-CD38 antibody conjugated to rhodamine (Becton Dickinson) (emission maximum: 545nm, red visible region) were used. The FoxP3 rabbit anti-human antibody was from abcam, and it was used with a fluorochrome-conjugated antirabbit goat IgG obtained from Sigma.
As previously described [16], slides were scanned at 40x magnification. The Aperio Imagescope software (Version 9.1.19.1569) was used for scoring, additional analysis and subsequent magnification. Two independent assessors evaluated the expression (signals) of each epitope based on the nuclear and cytoplasmic stains. A circle of tissue on the TMA was scored from 0 to 100, based on the extent of stain signals over the tissue. A score of 50 was interpreted as staining covering half of a circle of tissue, score of 75 means ¾ of the tissue were stained, while a score of 10 simply covers a small arc of a circle of tissue. Expressions of markers were ranked as low (signal scores: 1-24), negative (signal scores: 0-10), and high (signal scores ≥25). Expression level of each EBV marker was assigned a score of +1. Pooled results for each sample gave a score of either +1 (EBV negative or very low), +2 (intermediate EBV 
Discussion:
Early experiments established the EBV status of the NpC microarrays. EBV staining is punctate, and was optimized by using three distinct antibodies against the epitopes for latent membrane protein expression of the early EBV antigen, for diffuse expression, and for expression of the nuclear EBV antigen. Samples with more definite reactivity with all three EBV markers were ranked EBV4+, and samples with the lesser reactivity with barely one of the EBV antigens tested were ranked EBV+1. The differences in EBV immunoreactivity appeared directly related to the functional activity of the cells, as determined by fractal analysis (Benoit fractal analysis, mean+SD Statistical analysis of these scores was rendered difficult due to the large amount of random error. However, Wilcoxon analyses disclosed a difference in scores of Akt and mTOR immunoreactivities between low and moderate EBV infection (EBV+1-EBV+3), compared to EBV+4 (p=0.0006 and p<1.7X10 -9 , respectively). Akt and mTOR immunostaining was strongly correlated, revealing as much as 45% shared variance.
Fractal analyses confirmed the interdependent nature of the relationship among PI3K, Akt and mTOR, with respect to cell dimension, and presumably active cell growth. PI3K and Akt immunostained EBV4+ were found to be overall larger, and presumably more metabolically active than EBV1+ cells (respectively, PI3K fractal comparison -EBV4+: 1.43+0.03 vs. EBV1+: 1.34+0.02; p=0.0009; Akt fractal comparison -EBV4+: 1.56+0.08 vs. EBV1+: 1.42+0.03; t test p=0.01295). By contrast, mTOR immunostained EBV4+ were not found to be significantly larger than EBV1+ cells (EBV4+: 1.47+0.12 vs. EBV1+: 1.38+0.019; p=0.11), an outcome more likely due to the large random error in measurement rather than to the lack of a biological effect.
Taken together, our IHC data could signify important deregulation in the mTOR pathway in EBV+ samples of NpC biopsies, reflected in part if alteration of the upstream regulatory activities of PI3K and Akt. The observations established a direct correspondence between the activation of these metabolic pathways and the intensity of EBV infection, as defined by the intensity of staining of three distinct EBV epitopes.
A second round of experiments sought to characterize which cell populations was mTOR-activated in these NpC samples. Tri-fluorescence IHF experiments confirmed complete overlap of cells immunostained for the NpC susceptibility antigen, ANKRD11 [4] , and for the ectoenzyme cyclic ADP ribose hydrolase, CD38, a common marker of lymphocyte activation [10] (Figure 1, panel A) . This important control ascertained the histologic nature of the NpC biopsies, which were expected to be of lympho-epithelial origin in the nasopharynx. By contrast, there appears to be relatively few TILs-T of the CD38 phenotype (Figure 1, panel B) , and these invading CD8+ do not express the activation marker CD38. Panel C in Figure 1 shows, nevertheless, that there is a substantial influx of immune cells in the NpC lesions, and that these infiltrating lymphocytes express both the CD38 activation marker, and the marker of regulatory immune cells, FoxP3, indicating a significant migration of Bregs in NpC. This observation is confirmed at lower magnification in Panel D, which shows the substantial accumulation of CD38+FoxP3+ cells within the blood vessels of NpC lesions. It is quite evident from panels E & F (Figure 1 ) that these migrating CD38+ lymphocytes correspond to the mTOR+ cells analyzed by fractal analysis. Noteworthy, migrating CD38+ lymphocytes are primarily viewed in the blood vessels of tissue samples taken adjacent to tumorigenic NpC (Figure 1, panels D  & E) , but are localized in the tissue parenchyma of the NpC lesions proper (Figure 1, panels C & F) .
We utilized confocal microscopy with reversed fluorochromes to verify our observations. Panel G of Figure 1 confirms the relative paucity of invading CD8+ cells in NpC. Furthermore, Panel H indicates that TILs in NpC found in the blood vessels or the tissue parenchyma are activated and express, in this present case, high levels of Akt, upstream of the activation of mTOR (Figure 1, panels E & F) . FoxP3 [20] , the marker of activation (CD38), and markers of transmembrane and transcytosolic signaling (PI3K, Akt, mTOR pathway). These observations suggest that the predominant immune surveillance mechanism for controlling NpC progression is mediated by the regulatory role of resident plasma B cell population, and Bregs. Recent evidence supports this working model by suggesting that Akt emits two mutually counter-balancing signals in regulating B cell differentiation and apoptosis: one involves mTOR activation, and the other remains to be elucidated [22] . Therefore, our data may not be an epiphenomenon, but rather suggest that the FoxP3+ Bregs population might play an important role in modulating the tumor microenvironment [19] of NpC, in a manner akin to other B cell-related immunemodulatory events [20] .
Conclusion

